p14ARF R21RfsTER47 [cytosol]

Stable Identifier
R-HSA-9646285
Type
Protein [EntityWithAccessionedSequence]
Species
Homo sapiens
Compartment
Synonyms
CDKN2A-4 R21RfsTER47, p14ARF Arg21ArgfsTER47, CDKN2A-4 Arg21ArgfsTER47, p14ARF 60ins16
p14ARF R21RfsTER47 [cytosol] icon
Locations in the PathwayBrowser for interactor UniProt:Q8AZK7 EBNA5
Literature References
PubMed ID Title Journal Year
11571653 A melanoma-associated germline mutation in exon 1beta inactivates p14ARF

Rizos, H, Puig, S, Badenas, C, Malvehy, J, Darmanian, AP, Jiménez, L, Milà, M, Kefford, RF

Oncogene 2001
External Reference Information
External Reference
Gene Names
CDKN2A, CDKN2, MLM
Chain
chain:1-132
Reference Transcript
Other Identifiers
0002570204
0005550397
1029
11718293_a_at
11753744_a_at
11753745_x_at
1713_s_at
18232
207039_at
209644_x_at
3201444
3201445
3201446
3201447
3201448
3201457
3201458
3201459
3201460
3201480
3201481
3201482
445
47838
73132_r_at
8160441
93
A_23_P43484
A_23_P43490
A_33_P3411628
AAA82236
AAB01737
AAC60649
AAH15960
AAH21998
AAM77919
AAP35666
AF527803
AL449423
BC015960
BC021998
BT007020
CAB000093
CAB000445
CAB018232
CAH70601
CCDS6511
CDKN2A
CDKN2A-210
CDKN2A-214
CH471071
EAW58600
EAW58601
ENSG00000147889
ENSP00000432664
ENSP00000462950
ENST00000530628
ENST00000530628.2
ENST00000579755
ENST00000579755.1
EntrezGene:1029
EntrezGene:CDKN2A
g1353569_3p_a_at
g1353569_3p_x_at
g4206166_3p_a_at
g4502748_3p_at
GE59038
GO:0000209
GO:0000278
GO:0002376
GO:0003674
GO:0003677
GO:0005515
GO:0005575
GO:0005622
GO:0005623
GO:0005634
GO:0005654
GO:0005730
GO:0005737
GO:0005739
GO:0006259
GO:0006364
GO:0006464
GO:0006469
GO:0006915
GO:0006919
GO:0006950
GO:0007005
GO:0007049
GO:0007050
GO:0007155
GO:0007568
GO:0008134
GO:0008150
GO:0008219
GO:0008283
GO:0008285
GO:0008637
GO:0009056
GO:0009058
GO:0010389
GO:0010628
GO:0016925
GO:0019789
GO:0030154
GO:0030234
GO:0030889
GO:0031647
GO:0031648
GO:0033088
GO:0033235
GO:0034641
GO:0034655
GO:0042254
GO:0043065
GO:0043226
GO:0045893
GO:0045944
GO:0048103
GO:0048856
GO:0050821
GO:0051301
GO:0051444
GO:0055105
GO:0070534
GO:0090398
GO:0097718
GO:1902510
GO:1904667
GO:1990000
GO:1990948
GO:2000059
GO:2000435
HGNC:1787
HPA047838
ILMN_1717714
ILMN_1744295
IPR010868
J3QRG6
K7ENC6
K7ES20
K7PML8
LRG_11
LRG_11t2
MIM:155601
MIM:155755
MIM:600160
MIM:606719
NM_058195
NP_478102
P42771
PF07392
S78535
U26727
U26727_at
U38945
UPI000003C67C
Participant Of
Other forms of this molecule
Modified Residues
Name
Replacement of residues 21 to 132 by RPAASEGFRGSHPAAHGGVGSARGARRCGPRADATEEPASRAAAAS
Disease
Name Identifier Synonyms
cancer 162 malignant tumor, malignant neoplasm, primary cancer
melanoma 1909 Naevocarcinoma, melanoma, melanoma, malignant melanoma, morphology (morphologic abnormality), malignant melanoma NOS (morphologic abnormality), malignant melanoma (disorder), malignant melanoma, malignant melanoma, malignant melanoma, malignant melanoma
Cross References
RefSeq
OpenTargets
GeneCards
PRO
Interactors (14)
Accession #Entities Entities Confidence Score Evidence (IntAct)
 UniProt:Q00987 MDM2  11 0.813 5
 UniProt:Q7Z6Z7 HUWE1  4 0.677 5
 IntAct:EBI-4399559 UBIQ      0.667 3
 UniProt:Q8TAQ5 ZNF420  2 0.644 8
 UniProt:Q9UER7 DAXX  2 0.611 8
 UniProt:Q14669 TRIP12  1 0.602 4
 UniProt:P06748 NPM1  5 0.564 2
 UniProt:Q07021 C1QBP  3 0.556 3
 UniProt:P04198 MYCN      0.556 3
 UniProt:P08047 SP1  1 0.544 4
 UniProt:Q8AZK7 EBNA5      0.543 5
 UniProt:P18146 EGR1  1 0.524 4
 UniProt:P04637 TP53  27 0.491 2
 UniProt:P22087 FBL  1 0.462 2